UAB Reporter - People
Tuesday, July 05, 2011

Obesity Society Awards announced

New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off dialysis.

Traveler's Health Clinic Director David Freedman says concerns the Germany strain of E. Coli will spread in America are minimal.

With the acquisition, UAB takes a significant step toward making sophisticated cell therapy a part of patient care.

The risk factors for stroke in the South also may be responsible for cognitive decline.

«PrevNext»
Page 6 of 8